✓
Open
7 Nov 2025
✓
Close
11 Nov 2025
3
Allotment
—
✓
Listing
Fri, Nov 14, 2025
Price Band
₹120 to ₹128
Issue Size
21,50,000 shares (agg. up to ₹28 Cr)
Lot Size
1,000 Shares
Listing Date
Fri, Nov 14, 2025
Latest GMP
₹9
Est. Gain
7.03%
✦ AI Insight
GMP Trend
14-11-2025₹9Est. ₹137+7.03%
13-11-2025₹9Est. ₹137+7.03%
12-11-2025₹9Est. ₹137+7.03%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 52.57x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Jul 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 56.29 | 42.53 | 33.88 | 29.75 |
| Total Income | 19.51 | 49.65 | 35.87 | 36.42 |
| Profit After Tax | 2.87 | 6.11 | 4.87 | 1.88 |
| EBITDA | 4.24 | 9.54 | 8.39 | 3.28 |
| NET Worth | 19.10 | 16.23 | 5.87 | 1.01 |
| Reserves and Surplus | 13.16 | 10.29 | 5.37 | 0.51 |
| Total Borrowing | 15.32 | 15.62 | 17.09 | 16.19 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹333.35 |
| Asston Pharmaceuticals Ltd. | SME | ₹27.56 Cr | ₹123 | 17.83 | ₹124.95 | +1.59% | ₹110.00 |
| Influx Healthtech Ltd. | SME | ₹58.57 Cr | ₹96 | 13.04 | ₹126.20 | +31.46% | ₹283.70 |
| Astonea Labs Ltd. | SME | ₹37.67 Cr | ₹135 | 27.36 | ₹135.65 | +0.48% | ₹289.00 |
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹210.00 |
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.51 |
| Sat Kartar Shopping Ltd. | SME | ₹33.80 Cr | ₹81 | 14.87 | ₹161.55 | +99.44% | ₹117.00 |
| Onyx Biotec Ltd. | SME | ₹29.34 Cr | ₹61 | 26.81 | ₹56.75 | -6.97% | ₹37.55 |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,860.60 |
| Amanta Healthcare Ltd. | Mainboard | ₹126.00 Cr | ₹126 | 34.59 | ₹141.75 | +12.50% | ₹201.86 |
| Anlon Healthcare Ltd. | Mainboard | ₹121.03 Cr | ₹91 | 17.67 | ₹91.73 | +0.80% | ₹15.61 |
| Senores Pharmaceuticals Ltd. | Mainboard | ₹582.11 Cr | ₹391 | 39.77 | ₹557.80 | +42.66% | ₹1,509.80 |
| Sai Life Sciences Ltd. | Mainboard | ₹3,042.62 Cr | ₹549 | 126.42 | ₹764.65 | +39.28% | ₹1,647.10 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities | 2.44 |
| 2 | Capital Expenditure towards Construction of a Storage Facility | 3.62 |
| 3 | Pre-payment/Repayment of outstanding Secured Loans | 1.86 |
| 4 | Product Registrations in other countries | 2.69 |
| 5 | Funding working capital requirements | 11.25 |
| 6 | General Corporate Purposes | 2.85 |
| 7 | Issue Expenses | 2.80 |
| Total | 27.52 |
About Curis Lifesciences IPO
Updated on Aug 5, 2026
Contact Details
Curis Lifesciences Ltd. AddressPF-23, GIDC Sanand-IIIndustrial EstateSanandAhmedabad, Gujarat, 382110+91 99045 22543cs@curisls.comVisit Website